BROOKS LABORATORIES
|
BROOKS LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹-20 Cr | ₹-38 Cr | ₹-24 Cr | ₹-8.99 Cr |
Adjustment | ₹23 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
Changes In working Capital | ₹-13 Cr | ₹11 Cr | ₹-24 Cr | ₹7.37 Cr |
Cash Flow after changes in Working Capital | ₹-9.88 Cr | ₹-14 Cr | ₹-37 Cr | ₹8.66 Cr |
Cash Flow from Operating Activities | ₹-9.68 Cr | ₹-14 Cr | ₹-37 Cr | ₹4.46 Cr |
Cash Flow from Investing Activities | ₹0.18 Cr | ₹0.49 Cr | ₹-25 Cr | ₹-5.13 Cr |
Cash Flow from Financing Activities | ₹9.60 Cr | ₹11 Cr | ₹64 Cr | ₹1.16 Cr |
Net Cash Inflow / Outflow | ₹0.10 Cr | ₹-2.58 Cr | ₹1.72 Cr | ₹0.49 Cr |
Opening Cash & Cash Equivalents | ₹0.02 Cr | ₹2.61 Cr | ₹0.88 Cr | ₹0.40 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹0.13 Cr | ₹0.02 Cr | ₹2.61 Cr | ₹0.88 Cr |
Compare Cashflow Statement of peers of BROOKS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BROOKS LABORATORIES | ₹419.6 Cr | -3.9% | 1.6% | -0.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,612.0 Cr | -1.7% | 1.7% | -12.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,589.0 Cr | -4.8% | -4.7% | 11.4% | Stock Analytics | |
CIPLA | ₹121,956.0 Cr | -4.2% | -4.4% | -7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,561.0 Cr | -2.7% | -1.9% | 4.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,397.0 Cr | -3.6% | 0.9% | -2.3% | Stock Analytics |
BROOKS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BROOKS LABORATORIES | -3.9% |
1.6% |
-0.6% |
SENSEX | -2.2% |
-0.6% |
-4% |
You may also like the below Video Courses